SPOTLIGHT: Drug scandals cause second-guessing

Recent drug news--from Zyprexa's weight gain-and-diabetes problem to Avandia's heart attack warning to the recent hoopla over Vytorin--have some people asking whether drug therapy is all it's cracked up to be. Report

Suggested Articles

It’s final: England won’t be covering AZ’s quick-selling Tagrisso in previously untreated non-small cell lung cancer patients with EGFR mutatations.

Top J&J meds have managed to hang onto market share in the face of new generics and biosims, but the drugmaker expects the pain to continue in 2020.

Lonza’s search for a new CEO is expected to be wrapped up this year as the CDMO homes in on a list of veterans from outside the company.